| abstract |
The present invention relates to a method of treating a pathological condition caused by the tumor necrosis factor. The method of treatment consists in administering benzidine as the base benzidine at a dosage level of 0.1 to 10 mg / kg body weight per day from 1 to 3 daily administrations for a period of time from 5 to 30 days, systemically or locally, to a patient whose pathological condition caused by the tumor necrosis factor is selected from the group consisting of septic shock, cachexia, general malaise associated with neoplastic disease, chronic viral infections and bacterial, degenerative diseases. |